Giá của Opus Genetics, Inc. là bao nhiêu (IRD)

Giá của Opus Genetics, Inc. (IRD) là $3.70

Mũ thị trường của Opus Genetics, Inc. là gì (IRD)

Giới hạn thị trường của Opus Genetics, Inc. (IRD) là $305.87M

Lịch sử giá Opus Genetics, Inc. (IRD)

Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on ophthalmology. The company is dedicated to discovering and commercializing innovative therapies to address significant unmet medical needs in patients suffering from refractive and retinal eye disorders. Its portfolio includes Phentolamine Ophthalmic Solution, currently used to reverse pharmacologically induced mydriasis (pupil dilation). This solution is also advancing through Phase III clinical trials for the treatment of presbyopia and impaired vision in dim light or at night. A leading candidate in its retinal pipeline is APX3330, a small-molecule inhibitor targeting the reduction oxidation effector factor-1 protein. APX3330 has successfully completed Phase II clinical trials for diabetic retinopathy. Furthermore, Opus Genetics is developing APX2009 and APX2014, two preclinical product candidates also aimed at various retinal indications. Originally founded in 2018 as Ocuphire Pharma, Inc., the company maintains its headquarters in Farmington Hills, Michigan.

Năm	Hiệu suất
2026 (TTM)	51.09%
2025	96.16%
2024	0.00%

Năm

Hiệu suất

2026 (TTM)

51.09%

2025

96.16%

2024

0.00%

Công ty	Giá cổ phiếu	Thay đổi 1năm%	Quốc gia
Vertex Pharmaceuticals Incorporated VRTX.US	$548.15	40.18%	US
Argenx SE ARGX.US	$1.03K	44.14%	NL
Moderna, Inc. MRNA.US	$153.87	538.73%	US
CSL Limited CSL.AX	$121.37	-11.93%	AU
Lonza Group AG LONN.SW	$748.60	4.92%	CH

Công ty

Giá cổ phiếu

Thay đổi 1năm%

Quốc gia